These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 984784)
21. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole. Eykyn S; Jenkins C; King A; Phillips I Antimicrob Agents Chemother; 1976 Apr; 9(4):690-5. PubMed ID: 1267441 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the chemotherapeutic and pharmacodynamic activities of cephradine, cephalothin, and cephaloridine in mice. Miraglia GJ; Renz KJ; Gadebusch HH Antimicrob Agents Chemother; 1973 Feb; 3(2):270-3. PubMed ID: 4790592 [TBL] [Abstract][Full Text] [Related]
23. In vitro activity of BL-s640 against gram-negative bacilli and Staphylococcus aureus compared with activity of four other semisynthetic cephalosporins. Vuye A; Pijck J; Soep H Antimicrob Agents Chemother; 1976 Mar; 9(3):422-32. PubMed ID: 1259401 [TBL] [Abstract][Full Text] [Related]
24. Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins. Barry AL; Thornsberry C; Jones RN; Fuchs PC; Gavan TL; Gerlach EH Am J Clin Pathol; 1978 Dec; 70(6):909-13. PubMed ID: 727174 [TBL] [Abstract][Full Text] [Related]
25. Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic. Ries K; Levison ME; Kaye D Antimicrob Agents Chemother; 1973 Feb; 3(2):168-74. PubMed ID: 4790584 [TBL] [Abstract][Full Text] [Related]
26. BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies. Weaver SS; LeBlanc BM; Bodey GP Antimicrob Agents Chemother; 1979 Feb; 15(2):318-22. PubMed ID: 426520 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli. Verbist L Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801 [TBL] [Abstract][Full Text] [Related]
28. Cefadroxil, a new broad-spectrum cephalosporin. Buck RE; Price KE Antimicrob Agents Chemother; 1977 Feb; 11(2):324-30. PubMed ID: 848939 [TBL] [Abstract][Full Text] [Related]
29. Microbiological activity of cefazedone as compared to cefazolin and cephalothin. Knothe H Arzneimittelforschung; 1979; 29(2a):378-81. PubMed ID: 39575 [TBL] [Abstract][Full Text] [Related]
30. The cephalosporins: activity and clinical use. Weinstein AJ Drugs; 1980 Aug; 20(2):137-54. PubMed ID: 6995096 [TBL] [Abstract][Full Text] [Related]
31. Study of cefoperazone's in vitro antibacterial activity, in comparison with other cephalosporins, on 512 gram-negative bacterial strains. Dainelli B; Magni A; Maragoni F; Berlutti F; Thaller MC; Filadoro F G Batteriol Virol Immunol; 1981; 74(1-6):8-14. PubMed ID: 6458528 [No Abstract] [Full Text] [Related]
32. In vitro and in vivo laboratory studies on three hydroxyiminophenylacetyl cephalosporins with particular reference to SK&F 80303, an unusually long-acting cephalosporin. Uri JV; Actor P; Zajac I; Pitkin DH; Phillips L; Guarini JR; Bartus HF; Polansky TJ; Dunn GL; Hoover JR; Weisbach JA J Antibiot (Tokyo); 1979 Nov; 32(11):1161-7. PubMed ID: 118958 [TBL] [Abstract][Full Text] [Related]
33. Ceftezole, a new cephalosporin C derivative I. In vitro and in vivo antimicrobial activity. Noto T; Nehashi T; Endo H; Saito M; Matsubara S J Antibiot (Tokyo); 1976 Oct; 29(10):1058-70. PubMed ID: 994325 [TBL] [Abstract][Full Text] [Related]
34. The in vitro spectrum of the cephalosporins. Washington JA Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595 [TBL] [Abstract][Full Text] [Related]
35. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin. Une T; Mitsuhashi S Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821 [TBL] [Abstract][Full Text] [Related]
36. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions. Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628 [TBL] [Abstract][Full Text] [Related]
37. Clinical bacteriology of cephazolin. McAllister TA; Tait SC; Perman MG; Park AC Scott Med J; 1976 Sep; 20(5):220-7. PubMed ID: 1265471 [TBL] [Abstract][Full Text] [Related]
38. 7-(2-aminomethylphenylacetamido)-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid. Gottstein WJ; Kaplan MA; Cooper JA; Silver VH; Nachfolger SJ; Granatek AP J Antibiot (Tokyo); 1976 Nov; 29(11):1226-9. PubMed ID: 993108 [TBL] [Abstract][Full Text] [Related]
39. Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics. Part 3: cephalosporins. Barza M; Miao PV Am J Hosp Pharm; 1977 Jun; 34(6):621-9. PubMed ID: 327800 [TBL] [Abstract][Full Text] [Related]
40. HR 756, the syn isomer of a new methoxyimino cephalosporin with unusual antibacterial activity. Chabbert YA; Lutz AJ Antimicrob Agents Chemother; 1978 Nov; 14(5):749-54. PubMed ID: 31836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]